Myos Rens Tech (MYOS) Stock News
NASDAQ:MYOS - Nasdaq -
MYOS Latest News, Press Relases and Analysis
MYOS RENS Technology Announces anticipated exchange ratio, immediately after the completion of the Merger
MYOS RENS Technology Announces Net Revenues Increase 39% for the Three Months Ended September 30, 2020
CEDAR KNOLLS, N.J., Nov. 6, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ('MYOS' or the 'Company') (NASDAQ: MYOS), an advanced nutrition company...
MYOS RENS Technology Announces Net Revenues Increase 39% for the Three Months Ended September 30, 2020
Net Revenues Increased 16% for the nine months ended September 30, 2020
MYOS RENS Technology, Inc. Appoints The S3 Agency to Help Build Awareness of Muscle Health Importance
S3 to implement public relations and social media efforts around the ability of Fortetropin®, MYOS' proprietary ingredient, to improve muscle health.
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTN and MYOS Shareholders About Its Ongoing Investigations
Mentions: NTN
WeissLaw LLP Reminds MJCO and MYOS Shareholders About Its Ongoing Investigations
Mentions: MJCO
What To Do In A MArket That Just Won't Cooperate
My August trading has gotten off to a wild start thanks to some huge wins in Ambow Education Holding Ltd. (NYSE: AMBO) and Datasea Inc. (NASDAQ: DTSS) on Monday that set me up...
FSLY, WDC among premarket losers
MicroVision (NASDAQ:MVIS) -30% on Q2 earnings.OraSure Technologies (NASDAQ:OSUR) -20% on Q2 earnings.Fastly (NYSE:FSLY) -18% on Q2 earnings.Blue Apron Holdings (NYSE:APRN) -18% on pricing equity offering.Inseego (NASDAQ:INSG) -15% on Q2 earnings.ADMA Biologics (NASDAQ:ADMA) -15% on Q2 earnings.Citius Pharmaceuticals (NASDAQ:CTXR) -15% after announcing "bought deal" offering.Sonos (NASDAQ:SONO) -13% on Q3 earnings.Houghton Mifflin Harcourt (NASDAQ:HMHC) -4% on Q2 earnings.Western Digital (NASDAQ:WDC) -12% on Q4 earnings.Wix.com (NASDAQ:WIX) -11% on Q2 earnings.Aileron Therapeutics (NASDAQ:ALRN) -11% on Q2 earnings.Caladrius Biosciences (NASDAQ:CLBS) -10% after CFO resigns.ADT (NYSE:ADT) -10% on Q2 earnings.MYOS RENS Technology (NASDAQ:MYOS) -9%.TherapeuticsMD (NASDAQ:TXMD) -9% on Q2 earnings.Professional Diversity Network (NASDAQ:IPDN) -9%.3D Systems (NYSE:DDD) -9% on Q2 earnings.Four Seasons Education (Cayman) (NYSE:FEDU) -8%.Infrastructure and Energy Alternatives (NASDAQ:IEA) -8%.MannKind (NASDAQ:MNKD) -8% on Q2 earnings.Transocean (NYSE:RIG) -8% after executing a private exchange agreement relating to the 0.5% Exchangeable Bonds due 2023.Proteostasis Therapeutics (NASDAQ:PTI) -7%.Menlo Therapeutics (NASDAQ:MNLO) -7% on Q2 earnings.Carnival (NYSE:CCL) -7% on launch of direct offering.WISeKey International Holding (NASDAQ:WKEY) -7%.Camping World Holdings (NYSE:CWH) -7% on Q2 earnings.
90 Biggest Movers From Yesterday
Gainers Biofrontera AG (NASDAQ: BFRA) shares jumped 378.6% to close at $26.80 on Wednesday. MYOS RENS Technology Inc. (NASDAQ: MYOS) shares surged 48.4% to close at $1.84 after...
RIOT, NEWR, LL and MARA among midday movers
Gainers: IMAC Holdings (NASDAQ:IMAC) +59%.MYOS RENS Technology (NASDAQ:MYOS) +50%.Marathon Patent Group (NASDAQ:MARA) +38%.Professional Diversity Network (NASDAQ:IPDN) +32%.Alimera Sciences (NASDAQ:ALIM) +32%.Aemetis (NASDAQ:AMTX) +29%.Team (NYSE:TISI) +28%.DarioHealth (NASDAQ:DRIO) +28%.Riot Blockchain (NASDAQ:RIOT) +27%.Key Tronic Corporation (NASDAQ:KTCC) +25%.Losers: Vapotherm (NYSE:VAPO) -38%.New Relic (NYSE:NEWR) -26%.Sintx Technologies (NASDAQ:SINT) -23%.EverQuote (NASDAQ:EVER) -21%.Axcelis Technologies (NASDAQ:ACLS) -19%.Alterity Therapeutics (NASDAQ:ATHE) -18%.Energizer Holdings (NYSE:ENR) -17%.Zhongchao (NASDAQ:ZCMD) -16%.Blucora (NASDAQ:BCOR) -16%.Lumber Liquidators Holdings (NYSE:LL) -16%.
Healthcare - Top 5 Gainers / Losers
Gainers: Biofrontera (NASDAQ:BFRA) +238%. MYOS RENS Technology (NASDAQ:MYOS) +58%.
MYOS RENS Technology's Net Revenues Increase 114% and Operating Expenses Decrease 26% for the Three Months Ended June 30, 2020
For the six months ended June 30, 2020, Net Revenues Increase 104% and Operating Expenses Decrease by 17%
SHAREHOLDER ALERT: WeissLaw LLP Reminds DCOM and MYOS Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: WeissLaw LLP Reminds GCAP and MYOS Shareholders About Its Ongoing Investigations
Mentions: GCAP
Miragen Therapeutics leads healthcare gainers; Mallinckrodt and Vaxart among losers
Gainers: Miragen Therapeutics (NASDAQ:MGEN) +31%. Oncternal Therapeutics (NASDAQ:ONCT) +20%.
MYOS RENS dismisses litigation with RENS Technology (NASDAQ:MYOS)
MYOS RENS Technology (MYOS -3.8%) has settled its pending litigation with RENS Technology and its President, Ren Ren.In addition, RENS has agreed to vote all of its shares of MYOS in favor of the proposed merger between MYOS and MedAvail.RENS has also waived its right to receive an ownership interest in the new private company focused on muscle health that will be spun-out from the Company upon the closing of the Merger; Mr.
DELL, NAK among premarket gainers
AC Immune (NASDAQ:ACIU) +76% on advancement of Alzheimer's vaccine study.Future FinTech (NASDAQ:FTFT) +79% on acquisition of nice talent asset management.Boxlight (NASDAQ:BOXL) +43%.Lannett (NYSE:LCI) +36% on exclusive distribution deal for levothyroxine.Mer Telemanagement (NASDAQ:MTSL) +17%.Technical Communications (NASDAQ:TCCO) +17%.Dell Technologies (NYSE:DELL) +11% on VMware spin news.Tiziana Life Sciences (NASDAQ:TLSA) +10% on submitting patent application for expanded use of foralumab.ARCA biopharma (NASDAQ:ABIO) +9%.Verb Technology (NASDAQ:VERB) +8%.One Stop Systems (NASDAQ:OSS) +8%.Mmtec (NASDAQ:MTC) +8%.Safe-T (NASDAQ:SFET) +7%.Northern Dynasty Minerals (NYSEMKT:NAK) +7%.AgEagle Aerial (NYSEMKT:UAVS) +5%.Color Star Technology (NASDAQ:HHT) +6%.Houghton Mifflin Harcourt (NASDAQ:HMHC) +6%.NextCure (NASDAQ:NXTC) +5%.MYOS RENS Technology (NASDAQ:MYOS) +5% on settlement of litigation with RENS technology.WiMi Hologram Cloud (NASDAQ:WIMI) +5%.
MYOS RENS Technology Inc. Announces Settlement of Litigation with RENS Technology Inc.
Moore Kuehn Encourages DCOM, MYOS, ADSW, and NVTA Investors to Contact Law Firm
SHAREHOLDER ALERT: WeissLaw LLP Investigates MYOS RENS Technology Inc.
Myos Rens rallies on encouraging Fortetropin data (NASDAQ:MYOS)
Nano cap MYOS RENS Technology (MYOS +8.7%) is up, albeit on below-average volume, on the heels of a study evaluating the impact of Fortetropin on the rate of muscle protein synthesis in older adults.